rs117065412

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016373.4(WWOX):​c.1238C>A​(p.Ser413Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0183 in 1,614,074 control chromosomes in the GnomAD database, including 306 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S413C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.014 ( 17 hom., cov: 33)
Exomes 𝑓: 0.019 ( 289 hom. )

Consequence

WWOX
NM_016373.4 missense

Scores

1
3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.66

Publications

10 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
MAF (HGNC:6776): (MAF bZIP transcription factor) The protein encoded by this gene is a DNA-binding, leucine zipper-containing transcription factor that acts as a homodimer or as a heterodimer. Depending on the binding site and binding partner, the encoded protein can be a transcriptional activator or repressor. This protein plays a role in the regulation of several cellular processes, including embryonic lens fiber cell development, increased T-cell susceptibility to apoptosis, and chondrocyte terminal differentiation. Defects in this gene are a cause of juvenile-onset pulverulent cataract as well as congenital cerulean cataract 4 (CCA4). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
MAF Gene-Disease associations (from GenCC):
  • Ayme-Gripp syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • cataract 21 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
  • cataract - microcornea syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cerulean cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulverulent cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fine-Lubinsky syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003261149).
BP6
Variant 16-79211789-C-A is Benign according to our data. Variant chr16-79211789-C-A is described in ClinVar as Benign. ClinVar VariationId is 241099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0137 (2088/152302) while in subpopulation NFE AF = 0.0215 (1462/68006). AF 95% confidence interval is 0.0206. There are 17 homozygotes in GnomAd4. There are 977 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WWOXNM_016373.4 linkc.1238C>A p.Ser413Tyr missense_variant Exon 9 of 9 ENST00000566780.6 NP_057457.1 Q9NZC7-1A0A411HBC7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WWOXENST00000566780.6 linkc.1238C>A p.Ser413Tyr missense_variant Exon 9 of 9 1 NM_016373.4 ENSP00000457230.1 Q9NZC7-1

Frequencies

GnomAD3 genomes
AF:
0.0137
AC:
2087
AN:
152184
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00350
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0151
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.00565
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0128
AC:
3186
AN:
248544
AF XY:
0.0132
show subpopulations
Gnomad AFR exome
AF:
0.00267
Gnomad AMR exome
AF:
0.00696
Gnomad ASJ exome
AF:
0.0210
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00661
Gnomad NFE exome
AF:
0.0204
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.0187
AC:
27391
AN:
1461772
Hom.:
289
Cov.:
89
AF XY:
0.0185
AC XY:
13443
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00266
AC:
89
AN:
33478
American (AMR)
AF:
0.00742
AC:
332
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
537
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00632
AC:
545
AN:
86248
European-Finnish (FIN)
AF:
0.00781
AC:
417
AN:
53384
Middle Eastern (MID)
AF:
0.0113
AC:
65
AN:
5768
European-Non Finnish (NFE)
AF:
0.0219
AC:
24351
AN:
1111954
Other (OTH)
AF:
0.0175
AC:
1054
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1908
3816
5725
7633
9541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
920
1840
2760
3680
4600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0137
AC:
2088
AN:
152302
Hom.:
17
Cov.:
33
AF XY:
0.0131
AC XY:
977
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00349
AC:
145
AN:
41582
American (AMR)
AF:
0.0150
AC:
230
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00622
AC:
30
AN:
4826
European-Finnish (FIN)
AF:
0.00565
AC:
60
AN:
10620
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0215
AC:
1462
AN:
68006
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
111
222
334
445
556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0178
Hom.:
105
Bravo
AF:
0.0134
TwinsUK
AF:
0.0275
AC:
102
ALSPAC
AF:
0.0246
AC:
95
ESP6500AA
AF:
0.00255
AC:
10
ESP6500EA
AF:
0.0218
AC:
181
ExAC
AF:
0.0127
AC:
1535
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0195
EpiControl
AF:
0.0204

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 23, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WWOX: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive spinocerebellar ataxia 12;C3463992:Developmental and epileptic encephalopathy, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 28 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive spinocerebellar ataxia 12 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.12
T;.
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.060
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-0.79
T
PhyloP100
4.7
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.51
N;N
REVEL
Uncertain
0.33
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.019
D;D
Polyphen
0.070
B;B
Vest4
0.32
ClinPred
0.020
T
GERP RS
5.7
Varity_R
0.24
gMVP
0.38
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117065412; hg19: chr16-79245686; COSMIC: COSV68371157; COSMIC: COSV68371157; API